MedPath

Improving Attention in Individuals With Long COVID-19

Not Applicable
Recruiting
Conditions
Long Covid
Interventions
Other: Music Group
Other: Attention Training
Registration Number
NCT06503874
Lead Sponsor
Shirley Ryan AbilityLab
Brief Summary

This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

Detailed Description

The goal of this project is to test the feasibility, acceptability and efficacy of an attention training intervention (Attention Process Training; APT-3) as a potential treatment for brain fog symptoms experienced by people with Long-Covid. There already is good empirical evidence to support the idea that the APT-3 treatment is feasible and effective in improving attention in people with acquired brain injuries, but information about its efficacy and acceptability in people with Long-Covid brain fog is lacking.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Aged 18-65 years.
  • A history of confirmed SARS-CoV-2 infection.
  • Subjective reports of cognitive symptoms that interfere with everyday activities, starting on or shortly after SARS-CoV-2 infection.
  • Continuation or development of Long-Covid brain fog 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation.
  • Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit Span subtest (WAIS- III13).
  • Able to use a keyboard.
  • Able to understand and communicate in English.
  • Able to consent independently.
Exclusion Criteria
  • Being hospitalized due to COVID-19 diagnosis for more than 3 days.
  • Pre-morbid neurological conditions that could potentially affect cognition, such as Parkinson's Disease, Alzheimer's Dementia, acquired brain injury.
  • Severe depression.
  • Currently enrolled in cognitive training or physical exercise training.
  • Receiving chemotherapy or radiation within last 6 months.
  • Active substance abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Music ProgramMusic GroupThis group will receive an enhanced music experience. They will listen to pre determined music for 30 minutes per day, 5 days a week, for 4 weeks (10 hours total over 4 weeks). This will be delivered in a hybrid model that will combine, in person, remote, and independent sessions, similar to the Attention Training group. Once they complete the music program, they will have the option to complete the Attention Training.
Attention TrainingAttention TrainingThe computer based APT-3 intervention will be delivered in a hybrid model that will combine in-person therapy sessions at Shirley Ryan AbilityLab and practice sessions which will be completed remotely. The dosing of each intervention training will be 30 minutes per day, 5 days a week, for 4 weeks (10 hours total over 4 weeks). The difficulty of the tasks in both interventions will increase progressively as the participants improve in their skills. APT-3 treatment will be administered by a trained and certified speech-language pathologist.
Primary Outcome Measures
NameTimeMethod
Number of participants who successfully completed at least 80% of the study tasks sessions2 years

Recording the number of participants who completed at least 80% of the study sessions out of the number of all participants who enrolled in the study.

Secondary Outcome Measures
NameTimeMethod
Change of scores in objective attention tests (i.e, CPT 3), pre- and post -intervention2 year

The Conners Continuous Performance Test Third Edition™ (Conners CPT 3™)

Trial Locations

Locations (1)

Shirley Ryan AbilityLab

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath